Mycoplasma pneumonia future or investigational therapies

Pneumonia Main Page
Mycoplasma pneumonia Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Mycoplasma pneumonia from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
Treatment
Medical Therapy
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Mycoplasma pneumonia future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Mycoplasma pneumonia future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Mycoplasma pneumonia future or investigational therapies
CDC on Mycoplasma pneumonia future or investigational therapies
Mycoplasma pneumonia future or investigational therapies in the news
Blogs on Mycoplasma pneumonia future or investigational therapies
Directions to Hospitals Treating Mycoplasma pneumonia
Risk calculators and risk factors for Mycoplasma pneumonia future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Future or Investigational Therapies

Basic diagnostic strategy in clinical practice includes serology and standard polymerase chain reaction (PCR). New diagnostic techniques (PCR-related methods) may enable more rapid diagnosis. Exploration of the role of M. pneumoniae in community-acquired pneumonia and as a potential cofactor in severe pneumonia.

Sources

http://www.cdc.gov/ncidod/dbmd/diseaseinfo/mycoplasmapneum_t.htm